Biolidics Limited

Biolidics partners Japan's Sysmex Corp for cancer-related R&D
SINGAPORE (Feb 20): Biolidics Limited has established a strategic partnership with Sysmex Corporation, a Tokyo Stock Exchange-listed supplier of hematology instruments, to collaborate on the development of laboratory assays in the field of circulating tumour cells. See: Biolidics selling 27.5 mil new shares at 28 cents each in conjunction with Catalist listing The endeavor will use ...